DE BRABANDERE C.
Board
1 director, last change in 2024Director (not named in the articles), permanent representative De Brabandere Cathérine
since 19-12-2023
earlier director, until 05-01-2024
listed in the 2025 annual accounts, filed on 06-07-2026
Permanent representatives 1
De Brabandere Cathérine
Permanent representative, for FARMACAT
in office according to the deed of 05-01-2024
Mandates through the years
2 names, the dashed line is todayFARMACAT
Director (not named in the articles)
Director (not named in the articles)
De Brabandere Ignace
Director
Director
BoardEarliermandate already running before its first mention
Mandates as a list
- FARMACAT
- Director (not named in the articles), from 31-05-2020 to date
- Director, until 05-01-2024
- De Brabandere Ignace
- Director, from 31-05-2020 to 05-01-2024
Control
99.2%
This company
DE BRABANDERE C.
Equity €649,294
Profit €169,650 in 2025
Capital
- Capital
- €62,000
- Shares
- 125
- Contribution per share
- €496
- Equity per share
- €5,194 in 2025
- Source
- deed of 05-01-2024
Owners through the years
as the annual accounts name themOwners as a list
Source: lists of holdings in the owners' accounts
Articles of association
deed of 05-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Saturday of May at 13:00